These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23252248)

  • 1. [Metabolic disturbances as a factor of the pathogenesis of hypertensive disease and its clinical outcomes].
    Kovalenko VN; Talayeva TV; Shumakov VA; Bratus VV
    Ter Arkh; 2012; 84(11):51-8. PubMed ID: 23252248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypertrygliceridemia as a factor of atherogenesis: significance and mechanisms of action].
    Ambroskina VV; Kriachok TA; Larionov OP; Bratus' VV; Talaieva TV
    Fiziol Zh (1994); 2008; 54(5):61-70. PubMed ID: 19058514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients.
    Bogdanski P; Suliburska J; Szulinska M; Stepien M; Pupek-Musialik D; Jablecka A
    Nutr Res; 2012 Jun; 32(6):421-7. PubMed ID: 22749178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
    Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A
    Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension.
    Kjeldsen SE; Rostrup M; Moan A; Mundal HH; Gjesdal K; Eide IK
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S32-9. PubMed ID: 1283768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertensive waist: first step of the screening for metabolic syndrome.
    Nita C; Hancu N; Rusu A; Bala C; Roman G
    Metab Syndr Relat Disord; 2009 Apr; 7(2):105-10. PubMed ID: 19032044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: a pilot study.
    Spirou A; Rizos E; Liberopoulos EN; Kolaitis N; Achimastos A; Tselepis AD; Elisaf M
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):256-61. PubMed ID: 17220472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family history of hypertension influences left ventricular diastolic function during chronic antihypertensive therapy.
    Grandi AM; Laurita E; Marchesi C; Maresca A; Solbiati F; Nicolini E; Gianni M; Guasti L; Venco A
    Am J Hypertens; 2007 Apr; 20(4):410-5. PubMed ID: 17386348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure-lowering response to amlodipine as a determinant of the antioxidative activity of small, dense HDL3.
    Hansel B; Girerd X; Bonnefont-Rousselot D; Bittar R; Chantepie S; Orsoni A; Bruckert E; Chapman MJ; Kontush A
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):317-25. PubMed ID: 21699274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of calcium channel blocker lercanidipine on lowgrade inflammation parameters in essential hypertension patients].
    Shurtz-Swirski R; Farah R; Sela S; Shapiro G; Klempef R; Snitkovski T; Kristal B
    Harefuah; 2006 Dec; 145(12):895-9, 942. PubMed ID: 17220028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome.
    Nashar K; Nguyen JP; Jesri A; Morrow JD; Egan BM
    Am J Hypertens; 2004 Jun; 17(6):477-82. PubMed ID: 15177518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of hypertension with cluster of insulin resistance syndrome factors: the Chennai Urban Population Study (CUPS-12).
    Deepa R; Pradeepa R; Shanthirani CS; Mohan V;
    Acta Diabetol; 2004 Jun; 41(2):49-55. PubMed ID: 15224205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus].
    Molnár GA; Wagner Z; Wagner L; Melegh B; Kószegi T; Degrell P; Bene J; Tamaskó M; Laczy B; Nagy J; Wittmann I
    Orv Hetil; 2004 Apr; 145(16):855-9. PubMed ID: 15156690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tonocardin in complex treatment of diabetes mellitus concurrent with hypertension].
    Balabolkin MI; Khasanova ER; Trukhina TV; Kreminskaia VM
    Ter Arkh; 2002; 74(12):38-41. PubMed ID: 12577838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled crossover study of coenzyme Q10 therapy in hypertensive patients with the metabolic syndrome.
    Young JM; Florkowski CM; Molyneux SL; McEwan RG; Frampton CM; Nicholls MG; Scott RS; George PM
    Am J Hypertens; 2012 Feb; 25(2):261-70. PubMed ID: 22113168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen-free radical decrease in hypertensive patients treated with lercanidipine.
    Incandela L; Belcaro G; Cesarone MR; De Sanctis MT; Griffin M; Cacchio M; Nicolaides AN; Bucci M; Barsotti A; Martines G; Cornelli U; Di Renzo A
    Int Angiol; 2001 Jun; 20(2):136-40. PubMed ID: 11533521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The presence and characteristics of interrelations between lipid metabolism disorder and systemic inflammation].
    Ambroskina VV; Kriachok TA; Larionov OP; Bratus' VV; Talaieva TV
    Fiziol Zh (1994); 2008; 54(3):36-46. PubMed ID: 18763578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocturnal blood pressure but not insulin resistance influences endothelial function in treated hypertensive patients.
    Konrad T; Franke S; Schneider F; Bär F; Vetter G; Winkler K
    J Hum Hypertens; 2011 Jan; 25(1):18-24. PubMed ID: 20237501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.